• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > News > KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening
NewsResearch

KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening

ME Desk
ME Desk
Published: December 8, 2023
Share
3 Min Read
KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening
SHARE

Riyadh, Saudi Arabia- King Faisal Specialist Hospital and Research Centre (KFSH&RC) proudly announces a significant milestone in healthcare with a pioneering breakthrough in Autism Spectrum Disorder (ASD) screening.

This achievement is a key part of KFSH&RC’s digital transformation journey, underscoring the institution’s commitment to excellence in healthcare services within Saudi Arabia. The United States Patent and Trademark Office (USPTO) has recognized the innovative approach by granting it registered patent application status. Additionally, it has been published in a Quartile 1 Journal, positioning it within the top 25% in its global domain.

This groundbreaking method is the first of its kind, designed specifically for the Saudi population, enhancing KFSH&RC’s global medical standing. It represents a significant leap forward in objective ASD screening, noted for its accuracy, sensitivity, and specificity. Tailored to the unique linguistic and cultural aspects of Saudi Arabia, this innovation offers an efficient and more accurate alternative, addressing the limitations of traditional, subjective screening methods.

Looking to the future, this approach holds the potential to track the progress of treatments and interventions. By overcoming the lengthy and subjective nature of current ASD diagnosis methods, KFSH&RC’s approach facilitates early detection and more effective treatment, enhancing patient quality of life and reducing the burdens on healthcare and educational institutions.

Technology behind the innovation

The technological innovation behind this method is noteworthy. Utilizing eye tracking and specific visual stimuli integrated with artificial intelligence, KFSH&RC demonstrates the successful application of cutting-edge technology in medical research. This collaboration with global experts and the use of sophisticated hardware and software emphasize the hospital’s commitment to precision and safety in medical procedures.

Moreover, The study involved a diverse group of male and female participants across a broad age range, highlighting the method’s applicability to various demographics. The focus on Autism Spectrum Disorder in this research showcases KFSH&RC’s dedication to addressing pressing healthcare challenges through innovative methods. The AI-based approach, suitable for all ages, genders, and conditions, requires only the patient’s engagement with a visual stimulus for effective screening.

Also Read: Jotun Paints UAE Joins Hands with Al Noor Training Centre for Inclusive Education

Furthermore, This achievement is a result of KFSH&RC’s expertise, augmented by global scientific collaborations. It highlights the hospital’s role as a leader in medical innovation and its steadfast commitment to improving healthcare standards both nationally and global.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Can we create the perfect food? Can we create the perfect food?
Next Article BD Receives FDA Clearance for Fingertip Blood Collection Device BD Receives FDA Clearance for Fingertip Blood Collection Device

Recent Posts

  • From market access to national ambition, gulf healthcare is playing a longer game
  • New Push for HIV Innovation and Access Aims to Accelerate Progress Toward 2030 Goals
  • WHO Discusses Digital Health and Humanization of Care at Scientific Conference
  • Rising Ebola Cases Deepen Humanitarian Crisis for Children in DR Congo
  • Burjeel holdings secures dual credit ratings and launches USD 1.5 billion sukuk programme
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: KFSHRC Announces Breakthrough in Autism Spectrum Disorder Screening
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?